Valuation: Samil Pharmaceutical Co.,Ltd

Market Cap 173B 128M 111M 105M 95.6M 179M 12.19B 179M 1.26B 485M 6.23B 479M 468M 20.07B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 339M 250K 218K 205K 187K 351K 23.89M 352K 2.46M 950K 12.2M 938K 918K 39.32M EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.3x
Free-Float
71.64%
Yield 2026 *
-
Yield 2027 * -
1 day-3.77%
1 week+12.84%
Current month+28.62%
1 month+27.58%
3 months+16.49%
6 months-21.29%
Current year-18.37%
1 week 6,920
Extreme 6920
8,400
1 month 5,910
Extreme 5910
8,400
Current year 5,500
Extreme 5500
12,860
1 year 5,500
Extreme 5500
12,860
3 years 5,500
Extreme 5500
19,500
5 years 5,500
Extreme 5500
19,500
10 years 3,154.55
Extreme 3154.545454
29,000
Manager TitleAgeSince
Chief Executive Officer 61 2017-12-31
Chief Executive Officer 45 -
Corporate Officer/Principal 53 2023-03-23
Director TitleAgeSince
Chairman 45 -
Director/Board Member 61 2012-12-31
Director/Board Member 63 2020-03-19
Date Insider Type Main position Quantity % Market Cap. Importance
5/15/25 Buy

Director

772 0.0036%
5/15/25 Buy

Director

1,200 0.0055%
5/15/25 Buy

Director

599 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
-3.77%+12.84%-26.83%+13.81% 125M
+1.01%+0.62%+14.33%+65.92% 46.34B
-1.02%-2.67%+38.33%+108.43% 37.12B
+0.67%+5.65%+11.99%+93.93% 12.13B
-0.08%+1.84%-9.44%+17.27% 11.7B
-0.19%-0.19%+19.59%+140.28% 8.99B
-0.08%-0.08%+25.52%+38.73% 7.25B
+0.55%+2.70%+22.72%+215.07% 7.27B
-0.06%+1.51%+38.94%-16.76% 7.13B
-0.67%+5.34%-39.90%+11.48% 5.16B
Average -0.36%+2.93%+9.52%+68.82% 14.32B
Weighted average by Cap. +0.09%+0.82%+18.97%+80.07%

Financials

2026 *2027 *
Net sales 235B 173M 151M 142M 130M 244M 16.55B 244M 1.71B 659M 8.45B 650M 636M 27.25B 267B 197M 172M 162M 147M 277M 18.81B 277M 1.94B 748M 9.6B 739M 723M 30.96B
Net income - -
Net Debt 166B 122M 107M 100M 91.68M 172M 11.69B 172M 1.21B 465M 5.97B 459M 449M 19.25B 174B 128M 112M 105M 96.09M 180M 12.26B 180M 1.26B 488M 6.26B 481M 471M 20.18B
Logo Samil Pharmaceutical Co.,Ltd
Samil Pharmaceutical Co Ltd is a Korean-based company primarily engaged in the manufacturing and sale of pharmaceuticals. The Company operates through two segments. The Pharmaceutical segment mainly manufactures gastrointestinal motility regulators, nutritional supplements, gastrointestinal treatments, antipyretic analgesics and anti-inflammatory drugs, liver disease treatments and antihistamines, and also sells products used for glaucoma, depression and dry eyes. The Other segment mainly provides related services and also provides rental services. The Company also engages in the development of new drugs for ophthalmic diseases, liver diseases and circulatory and musculoskeletal conditions.
Employees
583
Date Price Change Volume
26-09-23 ₩8,100.00 +2.40% 105,783
26-09-22 ₩7,910.00 -3.77% 101,277
26-09-21 ₩8,220.00 +5.93% 240,013
26-09-18 ₩7,760.00 +3.88% 157,268
26-09-17 ₩7,470.00 +6.26% 145,661
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7,910.00KRW
Average target price
10,000.00KRW
Spread / Average Target
+26.42%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000520 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!